|
| 1 |
Isomangiferin, a Novel Potent Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor, Suppresses Breast Cancer Growth, Metastasis and Angiogenesis
Banghua Wang, Jia Shen, Zexia Wang, Jianxia Liu, Zhifeng Ning, Meichun Hu
|
|
| 2 |
Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
Li-Tzong Chen, Do-Youn Oh, Min-Hee Ryu, Kun-Huei Yeh, Winnie Yeo, Roberto Carlesi, Rebecca Cheng, Jongseok Kim, Mauro Orlando, Yoon-Koo Kang
Cancer Res Treat.2017;49(4):851-868. Published online 2017 January 3
DOI: http://dx.doi.org/10.4143/crt.2016.176
|
|
| 3 |
Diseases having an influence on inhibition of angiogenesis as risk factors of osteonecrosis of the jaw
Seung Jae Paek, Won-Jong Park, Ho-Sung Shin, Moon-Gi Choi, Kyung-Hwan Kwon, Eun Joo Choi
|
|
| 4 |
Influence of vascular endothelial growth factor inhibition on simple renal cysts in patients receiving bevacizumab-based chemotherapy
Tal Grenader, Linda Shavit
Korean J Urol.2015;56(12):791-795. Published online 2015 December 10
DOI: http://dx.doi.org/10.4111/kju.2015.56.12.791
|
|
| 5 |
Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis
Sang Hun Lee, Dongjun Jeong, Yong-Seok Han, Moo Jun Baek
|
|
| 6 |
The Anti-angiogenic Effect of Chlorogenic Acid on Choroidal Neovascularization
Cinoo Kim, Hyeong Gon Yu, Joonhong Sohn
|
|
| 7 |
Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
Jin Young Choi, Jaewan Choi, Yeon-Deok Kim
|
|
| 8 |
Targeted Therapy in Metastatic Renal Cell Carcinoma
Yong Hyun Park, Min Yong Kang, In Sik Hwang, Chan Soo Park, Sung Han Kim, Ja Hyun Ku, Cheol Kwak, Hyeon Hoe Kim
|
|
